Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making

Psychopharmacology

Volumn 231, Issue 3, 2014, Pages 521-531

  Abela, Andrew R ^a   Chudasama, Yogita ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Delay discounting; Dopamine; Noradrenaline; Prefrontal cortex; Rat; Reward

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BACLOFEN; GUANFACINE; MUSCIMOL; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZAZEPINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DELAY DISCOUNTING; DOSE RESPONSE; HIPPOCAMPUS; IMPULSIVENESS; MALE; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REWARD; TASK PERFORMANCE; VENTRAL HIPPOCAMPUS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; METABOLISM; PHYSIOLOGY; TIME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BACLOFEN; BENZAZEPINES; CONDITIONING, OPERANT; DELAY DISCOUNTING; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA-A RECEPTOR AGONISTS; GABA-B RECEPTOR AGONISTS; GUANFACINE; HIPPOCAMPUS; IMPULSIVE BEHAVIOR; MALE; MUSCIMOL; RATS, LONG-EVANS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D1; RECEPTORS, GABA-A; RECEPTORS, GABA-B; REWARD; TIME FACTORS;

EID: 84892812746     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3262-y     Document Type: Article

References (91)

1. Abela AR, Chudasama Y (2013) Dissociable contributions of the ventral hippocampus and orbitofrontal cortex to decision-making with a delayed or uncertain outcome. Eur J Neurosci 37:640-647
2. Abela AR, Dougherty SD, Fagen ED et al (2013) Inhibitory control deficits in rats with ventral hippocampal lesions. Cereb Cortex 23:1398-1409
3. Adell A, Garcia-Marquez C, Armario A, Gelpi E (1988) Chronic stress increases serotonin and noradrenaline in rat brain and sensitizes their responses to a further acute stress. 50:1678-1681
4. Arnsten AFT (1996) The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:448-455
5. Arnsten AFT, Li B-M (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384
6. Arnsten AF, Cai JX, Goldman-Rakic PS (1988) The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8:4287-4298
7. Balldin J, Berggren U, Eriksson E et al (1993) Guanfacine as an alpha-2-agonist inducer of growth hormone secretion - a comparison with clonidine. Psychoneuroendocrinology 18:45-55
8. Bari A, Mar AC, Theobald DE et al (2011) Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci 31:9254-9263
9. Bergson C, Mrzljak L, Smiley JF et al (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15:7821-7836
10. Boyson SJ, McGonigle P, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6:3177-3188
11. Brown CM, MacKinnon AC, McGrath JC et al (1990) Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol 99:803-809
12. Bymaster FP, Katner JS, Nelson DL et al (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711
13. Camps M, Kelly PH, Palacios JM (1990a) Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80:105-127
14. Camps M, Kelly PH, Palacios JM (1990b) Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species. J Neural Transm 80:105-127
15. Cardinal RN, Aitken MRF (2010) Whisker: a client-server high-performance multimedia research control system. Behav Res Methods 42:1059-1071
16. Cardinal RN, Pennicott DR, Sugathapaia CL et al (2001) Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292:2499-2501
17. Chamberlain SR, Del Campo N, Dowson J et al (2007) Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62:977-984
18. Cheung THC, Cardinal RN (2005) Hippocampal lesions facilitate instrumental learning with delayed reinforcement but induce impulsive choice in rats. BMC Neurosci 6:36
19. Chudasama Y, Doobay VM, Liu Y (2012) Hippocampal-prefrontal cortical circuit mediates inhibitory response control in the rat. J Neurosci 32:10915-10924
20. Cornish LA (1988) Guanfacine hydrochloride: a centrally acting antihypertensive agent. Clin Pharm 7:187-197
21. Dubocovich ML (1984) Presynaptic alpha-adrenoceptors in the central nervous system. Ann N Y Acad Sci 430:7-25
22. Dubois A, Savasta M, Curet O, Scatton B (1986) Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19:125-137
23. Fellows LK, Farah MJ (2005) Dissociable elements of human foresight: a role for the ventromedial frontal lobes in framing the future, but not in discounting future rewards. Neuropsychologia 43:1214-1221
24. Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844-914
25. Gasbarri A, Packard MG, Campana E, Pacitti C (1994) Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation in the rat. Brain Res Bull 33:445-452
26. Glavin GB, Tanaka M, Tsuda A et al (1983) Regional rat brain noradrenaline turnover in response to restraint stress. Pharmacol Biochem Behav 19:287-290
27. Gupta R, Duff MC, Denburg NL et al (2009) Declarative memory is critical for sustained advantageous complex decision-making. Neuropsychologia 47:1686-1693
28. Gutbrod K, Krouzel C, Hofer H et al (2006) Decision-making in amnesia: do advantageous decisions require conscious knowledge of previous behavioural choices? Neuropsychologia 44:1315-1324
29. Happe HK, Coulter CL, Gerety ME et al (2004) Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience 123:167-178
30. Harmer CJ, Hill SA, Taylor MJ et al (2003) Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160:990-992
31. Howland JG, Harrison RA, Hannesson DK, Phillips AG (2008) Ventral hippocampal involvement in temporal order, but not recognition, memory for spatial information. Hippocampus 18:251-257
32. Hunt RD, Capper L, O'Connell P (1990) Clonidine in child and adolescent psychiatry. J Child Adolesc Psychopharmacol 1:87-102
33. Hunt RD, Arnsten AFT, Asbell MD (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50-54
34. Johnson A, van der Meer MAA, Redish AD (2007) Integrating hippocampus and striatum in decision-making. Curr Opin Neurobiol 17:692-697
35. Johnston AL, File SE (1989) Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 32:151-156
36. Kim BK, Zauberman G (2009) Perception of anticipatory time in temporal discounting. J Neurosci Psychol Econ 2:91-101
37. Kim S, Bobeica I, Gamo NJ et al (2012) Effects of α-2A adrenergic receptor agonist on time and risk preference in primates. Psychopharmacology 219:363-375
38. Kwan D, Craver CF, Green L et al (2012) Future decision-making without episodic mental time travel. Hippocampus 22:1215-1219
39. Labudda K, Frigge K, Horstmann S et al (2009) Decision making in patients with temporal lobe epilepsy. Neuropsychologia 47:50-58
40. Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337-362
41. Loos M, Pattij T, Janssen MCW et al (2010) Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. Cereb Cortex 20:1064-1070
42. Mar AC, Walker ALJ, Theobald DE et al (2011) Dissociable effects of lesions to orbitofrontal cortex subregions on impulsive choice in the rat. J Neurosci 31:6398-6404
43. Mariano TY, Bannerman DM, McHugh SB et al (2009) Impulsive choice in hippocampal but not orbitofrontal cortex-lesioned rats on a nonspatial decision-making maze task. Eur J Neurosci 30:472-484
44. McCune SK, Voigt MM, Hill JM (1993) Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience 57:143-151
45. McHugh SB, Campbell TG, Taylor AM et al (2008) A role for dorsal and ventral hippocampus in inter-temporal choice cost-benefit decision making. Behav Neurosci 122:1-8
46. Milner TA, Lee A, Aicher SA, Rosin DL (1998) Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes. J Comp Neurol 395:310-327
47. Morrow BA, George TP, Roth RH (2004) Noradrenergic α-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry. Brain Res 1027:173-178
48. Nicholas AP, Pieribone V, Hökfelt T (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328:575-594
49. Pardey MC, Kumar NN, Goodchild AK, Cornish JL (2012) Catecholamine receptors differentially mediate impulsive choice in the medial prefrontal and orbitofrontal cortex. J Psychopharmacol 27:203-212
50. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. Academic Press
51. Peters J, Büchel C (2010) Episodic future thinking reduces reward delay discounting through an enhancement of prefrontal-mediotemporal interactions. Neuron 66:138-148
52. Peters J, Büchel C (2011) The neural mechanisms of inter-temporal decision-making: understanding variability. Trends Cogn Sci 15:227-239
53. Pickel VM, Segal M, Bloom FE (1974) A radioautographic study of the efferent pathways of the nucleus locus coeruleus. J Comp Neurol 155:15-41
54. Prasad JA, Chudasama Y (2013) Viral tracing identifies parallel disynaptic pathways to the hippocampus. J Neurosci 33:8494-8503
55. Rawlins JNP, Feldon J, Butt S (1985) The effects of delaying reward on choice preference in rats with hippocampal or selective septal lesions. Behav Brain Res 15:191-203
56. Robbins TW, Arnsten AFT (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267
57. Robinson ESJ, Eagle DM, Mar AC et al (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037
58. Rudebeck PH, Walton ME, Smyth AN et al (2006) Separate neural pathways process different decision costs. Nat Neurosci 9:1161-1168
59. Sallee FR, Mcgough J, Wigal T et al (2009) Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 48:155-165
60. Sastry BSR, Phillis JW (1977) Evidence that clonidine can activate histamine h2-receptors in rat cerebral cortex. Neuropharmacology 16:223-225
61. Savasta M, Dubois A, Scatton B (1986) Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390. Brain Res 375:291-301
62. Scahill L (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074
63. Scatton B, Simon H, Le Moal M, Bischoff S (1980) Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18:125-131
64. Schacter D, Addis D, Buckner RL (2007) Remembering the past to imagine the future: the prospective brain. Nat Rev Neurosci 8:657-661
65. Scheinin M, Lomasney JW, Hayden-Hixson DM et al (1994) Distribution of α2-adrenergic receptor subtype gene expression in rat brain. Mol Brain Res 21:133-149
66. 2+ and its presynaptic alpha2-adrenergic modulation. Naunyn Schmiedeberg's Arch Pharmacol 323:188-192. doi: 10.1007/BF00497661
67. Schoffelmeer AN, Hogenboom F, Mulder AH (1985) Evidence for a presynaptic adenylate cyclase system facilitating [3H]norepinephrine release from rat brain neocortex slices and synaptosomes. J Neurosci 5:2685-2689
68. Schoffelmeer AN, Wierenga EA, Mulder AH (1986) Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices. J Neurochem 46:1711-1717
69. Seamans JK, Floresco SB, Phillips AG (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18:1613-1621
70. Sellitto M, Ciaramelli E, di Pellegrino G (2010) Myopic discounting of future rewards after medial orbitofrontal damage in humans. J Neurosci 30:16429-16436
71. Shafiei N, Gray M, Viau V et al (2012) Acute stress induces selective alterations in cost-benefit decision-making. Neuropsychopharmacology 37:2194-2209
72. Shiels K, Hawk LW, Reynolds B et al (2009) Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 17:291-301
73. Sinz H, Zamarian L, Benke T et al (2008) Impact of ambiguity and risk on decision making in mild Alzheimer's disease. Neuropsychologia 46:2043-2055
74. Stine SM, Southwick SM, Petrakis IL et al (2002) Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol Psychiatry 51:642-651
75. Stopper CM, Green EB, Floresco SB (2012) selective involvement by the medial orbitofrontal cortex in biasing risky, but not impulsive, choice. Cereb Cortex. doi: 10.1093/cercor/bhs297
76. Sun H, Green TA, Theobald DEH et al (2010) Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry 67:649-656
77. Swann AC, Birnbaum D, Jagar AA et al (2005) Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry 57:1209-1211
78. Swanson LW (1981) A direct projection from Ammon's horn to prefrontal cortex in the rat. Brain Res 217:150-154
79. Swanson CJ, Perry KW, Koch-Krueger S et al (2006) Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50:755-760
80. Tanaka M, Kohno Y, Nakagawa R et al (1982) Time-related differences in noradrenaline turnover in rat brain regions by stress. Pharmacol Biochem Behav 16:315-319
81. Tanaka M, Kohno Y, Nakagawa R et al (1983) Regional characteristics of stress-induced increases in brain noradrenaline release in rats. Pharmacol Biochem Behav 19:543-547
82. Thierry AM, Gioanni Y, Dégénétais E, Glowinski J (2000) Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 10:411-419
83. Uhlén S, Wikberg JES (1991) Delineation of rat kidney α2A- and α2B-adrenoeeptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an α2A-selective compound. Eur J Pharmacol 202:235-243
84. Uhlén S, Muceniece R, Rangel N et al (1995) Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Pharmacol Toxicol 76:353-364
85. Unnerstall JR, Kopajtic TA, Kuhar MJ (1984) Distribution of α2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res Rev 7:69-101
86. van der Meer MAA, Johnson A, Schmitzer-Torbert NC, Redish AD (2010) Triple dissociation of information processing in dorsal striatum, ventral striatum, and hippocampus on a learned spatial decision task. Neuron 67:25-32
87. van Gaalen MM, van Koten R, Schoffelmeer ANM, Vanderschuren LJMJ (2006) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60:66-73
88. Winstanley CA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol 164:1301-1321
89. Winstanley CA, Theobald DEH, Cardinal RN, Robbins TW (2004) Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 24:4718-4722
90. Zauberman G, Kim BK, Malkoc SA, Bettman JR (2009) Discounting time and time discounting: subjective time perception and intertemporal preferences. J Mark Res 46:543-556
91. Zeeb FD, Floresco SB, Winstanley CA (2010) Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues. Psychopharmacology 211:87-98